Valuation: Monto Minerals Ltd

Market Cap 43.1M 29.76M 26.09M 24.05M 22.52M 42.23M 2.81B 289M 112M 1.39B 112M 109M 4.81B P/E 2024
-1.36x
P/E 2025 -3.77x
Enterprise Value 43.08M 29.74M 26.08M 24.04M 22.51M 42.2M 2.81B 289M 112M 1.39B 112M 109M 4.81B EV / Sales 2024
9.78x
EV / Sales 2025 21.1x
Free-Float
59.45%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 1994-01-16
Chief Executive Officer - 2026-05-10
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 2025-10-20
Director/Board Member - 2025-10-20
Chairman - 2025-11-25
Change 5-day change 1-year change 3-year change Capi.($)
+8.40%+11.78%-39.54%-15.04% 27.84B
+1.88%+9.31%-32.68%+189.21% 13.62B
-1.01%-1.08%-20.41%+57.72% 5.43B
+1.92%+5.98% - - 3.07B
+0.30%+13.66% - - 2.11B
+1.52%+2.77%+36.59%-41.96% 1.83B
-1.43%-7.17%-31.18% - 1.22B
+1.84%+0.87%-35.74%+246.20% 740M
-1.55%+29.80%+606.67%+863.64% 726M
Average +1.32%+7.15%+69.10%+216.63% 6.29B
Weighted average by Cap. +4.63%+9.05%-23.62%+63.87%

Financials

2024 2025
Net sales 398K 275K 241K 222K 208K 390K 25.9M 2.67M 1.03M 12.8M 1.03M 1.01M 44.38M 322K 222K 195K 180K 168K 315K 20.97M 2.16M 836K 10.37M 835K 817K 35.94M
Net income -3.13M -2.16M -1.9M -1.75M -1.64M -3.07M -204M -21M -8.12M -101M -8.12M -7.94M -349M -1.45M -1M -876K -808K -756K -1.42M -94.3M -9.71M -3.76M -46.6M -3.75M -3.67M -162M
Net Debt -375K -259K -227K -209K -196K -367K -24.4M -2.51M -972K -12.06M -971K -950K -41.82M -25.17K -17.38K -15.24K -14.04K -13.15K -24.65K -1.64M -169K -65.31K -810K -65.25K -63.82K -2.81M
Logo Monto Minerals Ltd
Opyl Limited is an Australia-based artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company, specialized in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored, actionable steps to address critical trial challenges, improving the likelihood of success. The Company is specialized in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-